AltuCell

Altucell, Inc. is a cell engineering and biotechnology company backed by solid research and science, dedicated to addressing the significant "unmet needs" for cellular, molecular, and regenerative therapies to treat diabetes and other autoimmune and neurodegenerative diseases. The company's proprietary and unique technology overcomes the major barriers of transplantation through a novel strategy employing patented microencapsulation technology, enabling transplantable cell-based therapies that evade detection and rejection by the immune system.